Amber L. Wells

3.8k total citations · 1 hit paper
26 papers, 3.0k citations indexed

About

Amber L. Wells is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Amber L. Wells has authored 26 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cell Biology. Recurrent topics in Amber L. Wells's work include Cardiomyopathy and Myosin Studies (10 papers), Muscle Physiology and Disorders (6 papers) and RNA Research and Splicing (6 papers). Amber L. Wells is often cited by papers focused on Cardiomyopathy and Myosin Studies (10 papers), Muscle Physiology and Disorders (6 papers) and RNA Research and Splicing (6 papers). Amber L. Wells collaborates with scholars based in United States, France and Morocco. Amber L. Wells's co-authors include H. Lee Sweeney, Robert H. Singer, E. Michael Ostap, Enrique M. De La Cruz, Steven S. Rosenfeld, Anne Houdusse, Hye Yoon Park, Carl Morris, Liqiong Chen and Julie Ménétrey and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Amber L. Wells

24 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myosin VI is an actin-based motor that moves backwards

1999 531 citations Amber L. Wells, Liqiong Chen et al. Nature profile →

Peers

Countries citing papers authored by Amber L. Wells

Since Specialization

Citations

This map shows the geographic impact of Amber L. Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber L. Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber L. Wells more than expected).

Fields of papers citing papers by Amber L. Wells

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber L. Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber L. Wells. The network helps show where Amber L. Wells may publish in the future.

Co-authorship network of co-authors of Amber L. Wells

This figure shows the co-authorship network connecting the top 25 collaborators of Amber L. Wells. A scholar is included among the top collaborators of Amber L. Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber L. Wells. Amber L. Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2688MO A phase I/II trial of FOG-001, a first-in-class direct β-catenin:TCF4 inhibitor - Safety and preliminary antitumor activity in patients with desmoid tumors 2025 ·Annals of Oncology ·Gregory M. Coté, Michael Cecchini, (unknown), Moh’d Khushman, (unknown), (unknown), Shivaani Kummar, (unknown), Sunil Sharma, Amber L. Wells, (unknown), Angela Garofalo, (unknown), Zhou Yu, Xinwei Han, Laura E. Strong, (unknown), Keith Orford, (unknown)	0
2	Phase 1/2 study of FOG-001, a first-in-class direct β-catenin:TCF inhibitor, in patients with colorectal cancer, hepatocellular carcinoma, and other locally advanced or metastatic solid tumors. 2025 ·Journal of Clinical Oncology ·Kyriakos P. Papadopoulos, Michael Cecchini, Moh’d Khushman, (unknown), Jordi Rodón, Shivaani Kummar, Rona Yaeger, Sunil Sharma, Amber L. Wells, (unknown), (unknown), Ziyang Yu, Varsha Iyer, (unknown), Keith Orford, Samuel J. Klempner	0
3	1597MO Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) 2024 ·Annals of Oncology ·(unknown), Manish R. Patel, (unknown), (unknown), (unknown), Jessica E. Hawley, S. Srinivas, (unknown), Vivek Narayan, Karie Runcie, Hamid Emamekhoo, (unknown), (unknown), Amber L. Wells, Raju Kandimalla, Satyendra Suryawanshi, Jiao Wu, Vivek Arora, Michael Pourdehnad, Amy J. Armstrong	2
4	First-in-human phase 1 study of CC-94676, a first-in-class androgen receptor (AR) ligand-directed degrader (LDD), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). 2024 ·Journal of Clinical Oncology ·Dana E. Rathkopf, Manish R. Patel, Atish D. Choudhury, Drew Rasco, Nehal J. Lakhani, Jessica E. Hawley, Ana M. Aparicio, Vivek Narayan, Sandy Srinivas, Karie Runcie, Hamid Emamekhoo, Zachery R. Reichert, Michael A. Carducci, Amber L. Wells, Can Liu, Raju Kandimalla, (unknown), (unknown), Michael Pourdehnad, Andrew J. Armstrong	8
5	The Value of Library and Information Services in Nursing and Patient Care 2014 ·OJIN The Online Journal of Issues in Nursing ·(unknown), Jennifer Morgan, Mary Lou Klem, Cheryl A. Thompson, Amber L. Wells	14
6	An Unbiased Analysis Method to Quantify mRNA Localization Reveals Its Correlation with Cell Motility 2012 ·Cell Reports ·Hye Yoon Park, Tatjana Trcek, Amber L. Wells, Jeffrey A. Chao, Robert H. Singer	53
7	β-Actin mRNA compartmentalization enhances focal adhesion stability and directs cell migration 2012 ·Genes & Development ·Zachary Katz, Amber L. Wells, Hye Yoon Park, Bin Wu, Shailesh M. Shenoy, Robert H. Singer	115
8	A transgenic mouse for in vivo detection of endogenous labeled mRNA 2011 ·Nature Methods ·Timothée Lionnet, Kevin Czaplinski, Xavier Darzacq, Yaron Shav‐Tal, Amber L. Wells, Jeffrey A. Chao, Hye Yoon Park, Valeria de Turris, Melissa Lopez-Jones, Robert H. Singer	296
9	Imaging Real-Time Gene Expression in Living Yeast 2007 ·Cold Spring Harbor Protocols ·Daniel Zenklusen, Amber L. Wells, John S. Condeelis, Robert H. Singer	9
10	Imaging Real-Time Gene Expression in Mammalian Cells with Single-Transcript Resolution: Figure 1. 2007 ·Cold Spring Harbor Protocols ·Amber L. Wells, John S. Condeelis, Robert H. Singer, Daniel Zenklusen	3
11	Biochemical and Structural Characterization of the Gem GTPase 2006 ·Journal of Biological Chemistry ·(unknown), Julie Ménétrey, Mylène Perderiset, (unknown), Karine Regazzoni, (unknown), Lucien Cabanié, Ahmed El Marjou, Amber L. Wells, Anne Houdusse, Jean de Gunzburg	31
12	The structure of the myosin VI motor reveals the mechanism of directionality reversal 2005 ·Nature ·Julie Ménétrey, Amel Bahloul, Amber L. Wells, Christopher M. Yengo, Carl Morris, H. Lee Sweeney, Anne Houdusse	181
13	Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors 2004 ·Cancer Research ·Weigang Wang, Sumanta Goswami, Kyle Lapidus, Amber L. Wells, Jeffrey Wyckoff, Erik Sahai, Robert H. Singer, Jeffrey E. Segall, John S. Condeelis	367
14	The unique insert in myosin VI is a structural calcium–calmodulin binding site 2004 ·Proceedings of the National Academy of Sciences ·Amel Bahloul, Guillaume Chevreux, Amber L. Wells, Davy Martin, (unknown), Zhaohui Yang, (unknown), Noëlle Potier, Alain Van Dorsselaer, Steve Rosenfeld, Anne Houdusse, H. Lee Sweeney	62
15	Calcium Functionally Uncouples the Heads of Myosin VI 2003 ·Journal of Biological Chemistry ·Carl Morris, Amber L. Wells, Zhaohui Yang, Liqiong Chen, (unknown), H. Lee Sweeney	39
16	An actin-dependent conformational change in myosin 2003 ·Nature Structural & Molecular Biology ·Ming Xiao, (unknown), Amber L. Wells, (unknown), (unknown), Pinghua Ge, H. Lee Sweeney, Paul R. Selvin	24
17	A structural state of the myosin V motor without bound nucleotide 2003 ·Nature ·Pierre‐Damien Coureux, Amber L. Wells, Julie Ménétrey, Christopher M. Yengo, Carl Morris, H. Lee Sweeney, Anne Houdusse	249
18	Myosin VI is an actin-based motor that moves backwards breakdown → 1999 ·Nature ·Amber L. Wells, (unknown), Liqiong Chen, Daniel Safer, (unknown), Tama Hasson, Bridget Carragher, Ronald A. Milligan, H. Lee Sweeney	531
19	The kinetic mechanism of myosin V 1999 ·Proceedings of the National Academy of Sciences ·Enrique M. De La Cruz, Amber L. Wells, Steven S. Rosenfeld, E. Michael Ostap, H. Lee Sweeney	344
20	In Vivo Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral Genes 1996 ·Human Gene Therapy ·(unknown), Hansell H. Stedman, Rita J. Balice‐Gordon, Daniel B. Smith, James P. Greelish, Marilyn A. Mitchell, Amber L. Wells, H. Lee Sweeney, James M. Wilson	123

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact